Bimonthly Survey

Please indicate if you have used resources and/or trainings from any of the following in the past 12 months.
Select all that apply

Description

Graphic image

Join the Southeast AETC for this five-session series that explores how to implement Long-Acting Injectables (LAI) in real-world settings by integrating clinical and nonclinical workflows, centering on patient experience and shared decision-making, optimizing prescribing practices, addressing coverage and access barriers, and using clinical monitoring and process indicators to drive quality improvement.

Objectives

  • Review the clinical trials that led to the approval of long-acting cabotegravir and rilpivirine, and understand their limitations
  • Interpret real-world data, including outcomes in patients not included in the original FDA label
  • Identify clinical and structural considerations when initiating and maintaining long-acting injectable ART
  • Discuss emerging long-acting therapies and how they may shape future treatment strategies

Speaker

Jason Zucker, MD
Assistant Professor of Medicine, Columbia University Irving Medical Center
PI and Co-Medical Director, New York City STD Prevention Training Center

For inquiry, contact Alexandria Anderson via [email protected]

More events in this series